Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidants for Preventing CIAKI After Coronary Catheterization
NCT03755700Phase 3Unknown
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Nov 2018
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in contrast-induced acute kidney injury (CI-AKI) comparing Placebo, Vitamin E and NAC (3 arms). Primary endpoint: Contrast-induced acute kidney injury. Status: unknown.
02
Drugs
vitamin eacetylcysteine
03
Conditions
contrast-induced acute kidney injury (CI-AKI)
Beyond the preview
Go deeper on NCT03755700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03755700.